HP
Hikari Power Portfolio holdings
AUM
$1.2B
This Quarter Return
-0.65%
1 Year Return
+14.18%
3 Year Return
+56.59%
5 Year Return
+122.08%
10 Year Return
+191.59%
AUM
$997M
AUM Growth
+$997M
(-1.6%)
Cap. Flow
-$4.08M
Cap. Flow
% of AUM
-0.41%
Top 10 Holdings %
Top 10 Hldgs %
68.44%
Holding
70
New
–
Increased
15
Reduced
2
Closed
2
Top Buys
| 1 |
RDS.B
Royal Dutch Shell PLC ADS Class B
RDS.B
|
$1.58M |
| 2 |
Exxon Mobil
XOM
|
$1.51M |
| 3 |
Altria Group
MO
|
$855K |
| 4 |
AbbVie
ABBV
|
$631K |
| 5 |
Vanguard Health Care ETF
VHT
|
$524K |
Top Sells
| 1 |
Wells Fargo
WFC
|
$11.2M |
| 2 |
NovoCure
NVCR
|
$377K |
| 3 |
Alibaba
BABA
|
$247K |
| 4 |
Bank of New York Mellon
BK
|
$85.5K |
Sector Composition
| 1 | Financials | 45.56% |
| 2 | Healthcare | 19.85% |
| 3 | Industrials | 6.7% |
| 4 | Materials | 6.24% |
| 5 | Energy | 4.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
AB InBev
BUD
$116B
| $6.14M | 0.62% |
108,860
| – | – |
|
27
Becton Dickinson
BDX
$54.3B
| $5.89M | 0.59% |
23,970
| – | – |
|
28
Boeing
BA
$176B
| $5.39M | 0.54% |
24,500
| – | – |
|
|
29
AbbVie
ABBV
$374B
| $5.28M | 0.53% |
48,963
+5,850
| +14% | +$631K |
|
30
Fortive
FTV
$15.9B
| $4.91M | 0.49% |
69,500
+1,290
| +2% | +$91K |
|
31
Cigna
CI
$80.2B
| $4.58M | 0.46% |
22,899
| – | – |
|
32
Mastercard
MA
$536B
| $3.48M | 0.35% |
10,000
| – | – |
|
33
Honeywell
HON
$136B
| $3.44M | 0.35% |
16,200
| – | – |
|
34
Vanguard FTSE Emerging Markets ETF
VWO
$96.5B
| $2.94M | 0.3% |
58,810
| – | – |
|
35
Coca-Cola
KO
$297B
| $2.54M | 0.25% |
48,400
| – | – |
|
36
Jack Henry & Associates
JKHY
$11.8B
| $2.43M | 0.24% |
14,800
+510
| +4% | +$83.7K |
|
37
Lockheed Martin
LMT
$105B
| $2.14M | 0.21% |
6,190
| – | – |
|
38
Berkshire Hathaway Class B
BRK.B
$1.08T
| $2.02M | 0.2% |
7,390
| – | – |
|
39
Bank of America
BAC
$371B
| $1.98M | 0.2% |
46,740
| – | – |
|
40
Cisco
CSCO
$268B
| $1.93M | 0.19% |
35,500
| – | – |
|
41
Vontier
VNT
$6.24B
| $1.88M | 0.19% |
56,086
+8,060
| +17% | +$271K |
|
42
Ametek
AME
$42.6B
| $1.65M | 0.17% |
13,270
+1,330
| +11% | +$165K |
|
43
Bristol-Myers Squibb
BMY
$96.7B
| $1.57M | 0.16% |
26,450
+7,410
| +39% | +$438K |
|
44
Anavex Life Sciences
AVXL
$817M
| $1.54M | 0.15% |
85,585
| – | – |
|
45
Merck
MRK
$210B
| $1.44M | 0.14% |
19,160
+4,100
| +27% | +$308K |
|
46
Gilead Sciences
GILD
$140B
| $1.3M | 0.13% |
18,630
| – | – |
|
|
STOR
47
DELISTED
STORE Capital Corporation
STOR
| $1.18M | 0.12% |
36,700
| – | – |
|
|
48
Vanguard Health Care ETF
VHT
$15.5B
| $1.09M | 0.11% |
4,420
+2,120
| +92% | +$524K |
|
49
Kraft Heinz
KHC
$31.9B
| $952K | 0.1% |
25,850
| – | – |
|
50
British American Tobacco
BTI
$120B
| $834K | 0.08% |
23,650
| – | – |
|